SCHEMBL13703447

SCHEMBL13703447

CCNC(=O)C(CSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CSCC(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@@H](CSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MDM2 Q00987 5/20 0.44
▸ MC4R P32245 1/20 0.44
▸ MC5R P33032 1/20 0.44
▸ MC3R P41968 1/20 0.44
▸ MC1R Q01726 1/20 0.44
▸ ESR1 P03372 2/20 0.42
▸ OXTR P30559 5/20 0.41
▸ AVPR1A P37288 5/20 0.41
▸ AVPR1B P47901 4/20 0.41
▸ CTSG P08311 2/20 0.41
▸ ALB P02768 1/20 0.40
▸ NPR1 P16066 1/20 0.40
▸ NPR3 P17342 1/20 0.40
▸ TSLP Q969D9 1/20 0.39
▸ BCL2L1 Q07817 1/20 0.38
▸ BAD Q92934 1/20 0.38
▸ PLAU P00749 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11929553 0.92 MC4R (0.46) MDM2MC4RMC5RMC3RMC1R
SCHEMBL13703200 0.83 MC4R (0.52) MC4RMC5RMC3RMC1RCTSG
SCHEMBL13703448 0.82 MC4R (0.53) MDM2MC4RMC5RMC3RMC1R
SCHEMBL13649555 0.81 MC4R (0.56) MC4RMC5RMC3RMC1RCTSG
SCHEMBL13649564 0.80 MC4R (0.55) MC4RMC5RMC3RMC1RCTSG
SCHEMBL13703202 0.79 MC4R (0.52) MC4RMC5RMC3RMC1RCTSG
SCHEMBL11929552 0.78 ITGB3 (0.57) MC4RMC5RMC3RMC1RCTSG
SCHEMBL13649552 0.77 MDM2 (0.51) MDM2ESR1OXTRAVPR1AAVPR1B
SCHEMBL13656564 0.77 MC4R (0.49) MDM2MC4RMC5RMC3RMC1R
SCHEMBL11929915 0.74 MC4R (0.58) MDM2MC4RMC5RMC3RMC1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090232741-A1 Optical Imaging GE HEALTHCARE AS (NO) 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090232741-A1 Optical Imaging AGER, KDR, FLT4 MDM2 4012/4885MC4R 244/4885MC5R 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback